As the coronavirus pandemic rages on, consumers are turning to ecommerce as a way to purchase everything from groceries to prescription medications. Now so-called “shadow pharmacies” are seeking to take advantage of pandemic fears and spending by claiming to sell unconfirmed coronavirus treatments without a prescription, according to a Babel Street report.
“As consumers make the shift to online...
Clinical lab and drug development giant LabCorp announced this morning a new deal that will streamline its adoption of virtual clinical trials.
The company's drug-development-focused contract research organization (CRO), Covance, will use digital clinical trial software-maker Medable's platform to fuel its patient and site interface. This will allow participants easy access to clinical trial apps...
insitro and Exscientia, two platforms using artificial intelligence to drive the discovery of new drugs, announced this morning the raise of $143 million and $60 million, respectively, from investors.
insitro's oversubscribed Series B round was headed by Andreessen Horowitz, and joined by new backers Canada Pension Plan Investment Board, T. Rowe Price Associates, BlackRock, Casdin Capital, HOF...
The COVID-19 pandemic has deeply affected us all. To honor those who have been lost and those who are working so hard to keep us well, HIMSS and its media brands will observe a digital day of silence and appreciation on May 18.
Cognitant Group has launched Healthinote, an app that provides patients with up-to-date, verified healthcare information to help them understand their conditions and treatment options better, and counters the potential impact of "fake news" on their decisions and outcomes.
With a search facility, a favourite page for users to save personalised information and a share function, the app also uses...
The traditional brick-and-mortar clinical research studies are getting a shakeup as digital comes onto the scene. The rapidly rising cost of clinical trials and the more recent coronavirus pandemic have put pressure on the industry to evolve.
“If you look at drug company trials, you see how much it is costing per participant. It is now at an exponential phase. It was unsustainable before and it...
Following numerous reports of underperforming COVID-19 antibody tests, the FDA has raised the bar for these products in a revision to its emergency testing policy.
As of today, commercial manufacturers that notify the agency of their intent to submit a test for Emergency Use Authorization are required to do so within 10 business days from the date of notification. Further, the FDA has recommended...
Less than a week after FDA opened the faucet for digital health products treating psychiatric conditions during the COVID-19 health crisis, Akili has fast-tracked and released its approval-pending digital therapeutic for children with ADHD.
Now known as Endeavor and flanked by a symptom tracker and caretaker support line, the video game-like app will be provided at no cost for a limited time to...
International pharma giant Novartis announced this morning the acquisition of Amblyotech, a startup that combines 3D glasses and video game software to treat amblyopia, more commonly known as "lazy eye." The terms of the deal were not disclosed.
Novartis also said that it will be developing new games and kicking off a proof-of-concept study alongside major French video game publisher Ubisoft and...
